Skip to content
10-Q

Quarterly Report

LAVA Therapeutics NV

0001558370-25-011407

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 26.31M sh
Shares Diluted Q2 2025 · Jun 30, 2025 26.9M sh
Shares Diluted Q2 2025 · Jun 30, 2025 26.89M sh
Shares Diluted Q2 2025 · Jun 30, 2024 26.82M sh
Shares Diluted Q2 2025 · Jun 30, 2024 26.81M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$25.39M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$9.06M
Short Term Investments Q2 2025 · Jun 30, 2025 $29.79M
Short Term Investments Q2 2025 · Dec 31, 2024 $41.56M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $26.38M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $35.02M
Stockholders Equity Q2 2025 · Jun 30, 2025 $19.94M
Stockholders Equity Q2 2025 · Mar 31, 2025 $25.78M
Stockholders Equity Q2 2025 · Dec 31, 2024 $27.75M
Stockholders Equity Q2 2025 · Jun 30, 2024 $42.92M
Stockholders Equity Q2 2025 · Mar 31, 2024 $50.81M
Stockholders Equity Q2 2025 · Dec 31, 2023 $51.36M
Current Liabilities Q2 2025 · Jun 30, 2025 $5.61M
Current Liabilities Q2 2025 · Dec 31, 2024 $18.01M
Total Liabilities Q2 2025 · Jun 30, 2025 $40.61M
Total Liabilities Q2 2025 · Dec 31, 2024 $53.09M
Current Assets Q2 2025 · Jun 30, 2025 $60.5M
Current Assets Q2 2025 · Dec 31, 2024 $79.3M
Total Assets Q2 2025 · Jun 30, 2025 $60.55M
Total Assets Q2 2025 · Dec 31, 2024 $80.83M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.32
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.45
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.31
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.33
Eps Basic Q2 2025 · Jun 30, 2025 −$0.32
Eps Basic Q2 2025 · Jun 30, 2025 −$0.45
Eps Basic Q2 2025 · Jun 30, 2024 −$0.31
Eps Basic Q2 2025 · Jun 30, 2024 −$0.33
Sga Expense Q2 2025 · Jun 30, 2025 $2.55M
Sga Expense Q2 2025 · Jun 30, 2025 $5.98M
Sga Expense Q2 2025 · Jun 30, 2024 $3.44M
Sga Expense Q2 2025 · Jun 30, 2024 $6.82M
Rd Expense Q2 2025 · Jun 30, 2025 $4.74M
Rd Expense Q2 2025 · Jun 30, 2025 $8.9M
Rd Expense Q2 2025 · Jun 30, 2024 $5.96M
Rd Expense Q2 2025 · Jun 30, 2024 $11.61M
Net Income Q2 2025 · Jun 30, 2025 −$8.64M
Net Income Q2 2025 · Jun 30, 2025 −$12.12M
Net Income Q2 2025 · Mar 31, 2025 −$3.48M
Net Income Q2 2025 · Jun 30, 2024 −$8.3M
Net Income Q2 2025 · Jun 30, 2024 −$8.91M
Net Income Q2 2025 · Mar 31, 2024 −$608K
Operating Income Q2 2025 · Jun 30, 2025 −$7.29M
Operating Income Q2 2025 · Jun 30, 2025 −$14.88M
Operating Income Q2 2025 · Jun 30, 2024 −$9.39M
Operating Income Q2 2025 · Jun 30, 2024 −$11.43M
Short Term Debt Q2 2025 · Dec 31, 2024 $4.89M
Revenue Q2 2025 · Jun 30, 2024 $6.99M